FiercePharmaOriginal article
{"a":[{"_":"FDA halts release of new drug rejection letters while working to formalize policy","$":{"href":"/biotech/fda-halts-release-new-drug-rejection-letters-while-working-formalize-policy","hreflang":"en"}}]}
RegulatoryNegative
AI Analysis
Summary
The FDA has paused its controversial policy of releasing rejection letters explaining rationale for drug denials, following an April citizen petition from an unnamed pharmaceutical company.
Outcome Details
FDA paused policy of releasing drug rejection letters following citizen petition
Importance:4/10
Sentiment:
-0.30
FDA policydrug rejection lettersregulatory transparency
Related Companies
Read the original article
Published by FiercePharma on July 8, 2026 1:06 PM